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Abstract
Background: Takayasu arteritis (TAK) is a systemic disease characterized by large vessel involvement. Although the
vascular characteristics of TAK are well characterized, there is no well-organized study demonstrating the extravascular
manifestations of TAK. We aimed to evaluate the characteristics of extravascular manifestations of TAK, and to identify
the association between vascular and extravascular manifestations of TAK.
Methods: TAK patients from two independent cohorts between January 2012 and October 2017 were included in the
study. Patient characteristics were retrospectively collected from the electronic dataset. The computed tomography
scans of all subjects were reviewed to evaluate the pattern of vascular involvement and presence of sacroiliitis. Clinical
findings including uveitis, skin lesions, oral ulcers, arthritis, and inflammatory bowel disease (IBD) were reviewed.
Logistic regression analysis was performed to evaluate the association between vascular and extravascular
manifestations.
Results: For the 268 TAK patients, the mean age at diagnosis was 41.2 ± 14.2 years and 88.1% were female. The
extravascular manifestation of TAK was observed in 19.0% of patients, the most common being arthritis including
sacroiliitis (11.9%) followed by recurrent oral ulcers (8.6%) and IBD (2.6%). A multivariate logistic regression analysis
revealed type IIB vascular involvement (adjusted odds ratio (OR) 2.956, 95% confidence interval (CI) 1.337–6.537, p = 0.007)
and the erythrocyte sedimentation rate (ESR) (adjusted OR 1.014, 95% CI 1.003–1.025, p = 0.012) as significantly associated
with the presence of axial and peripheral arthritis.
Conclusions: Extravascular manifestations of TAK were observed in up to one-fifth of patients. The most common
extravascular manifestation was arthritis, which was associated with a type IIB vascular involvement pattern and a high
ESR.
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Background
Takayasu arteritis (TAK) is a systemic vasculitis mainly
involving the aorta and its major branches and can cause
occlusive or aneurysmal degeneration [1]. The preva-
lence of TAK in Japan was estimated at 40 per 1 million
of population, with a female predominance [2]. The
prevalence of TAK in European studies is lower than
that in Japan, being 4.7–13.2 per 1 million of population
[3–5].
Despite this rarity, based on a number of previous
studies [1, 6–11], knowledge regarding TAK has much
improved since its first report in Japan in 1908 [12]. In
particular, the vascular manifestations of TAK have been
well reported in previous studies [1, 6–11]. Although
there might be some discrepancies among different eth-
nic populations, the largest scale observational study
conducted in Japan [1] reported that local symptoms
and findings attributable to vascular involvement were
most commonly observed in the cervicobrachial area.
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Accordingly, the majority of the patients exhibited vas-
cular involvements of the aortic arch or its major
branches, which supply the cervicobrachial area. Fur-
thermore, the most common type of angiographic in-
volvement according to Hata’s classification [13] was
type I (branches of the aortic arch).
Although the vascular manifestations of TAK are well
known, the extravascular manifestations of TAK remain
unclear. Some recent studies have addressed spondyloar-
thritis (SpA) [14, 15] and inflammatory bowel disease
(IBD) [16, 17] in TAK patients. However, only sporadic
case reports regarding other extravascular manifestations
such as erythema nodosum [18–20] and uveitis [21, 22]
have been reported. Moreover, peripheral arthritis has
occasionally been observed in TAK patients, but data
concerning these manifestations are not well established.
Therefore, we aimed to identify the characteristics of
extravascular manifestations of TAK. Furthermore, we
evaluated the association between vascular and extravas-
cular manifestations of TAK.
Methods
Study population
Two independent cohorts from two tertiary referral hos-
pitals in South Korea were included. All study subjects
were diagnosed with TAK and encoded M314 according
to the International Statistical Classification of Diseases
and Related Health Problems, Tenth Revision (ICD-10)
between January 2012 and October 2017. All patients
met the 1990 American College of Rheumatology (ACR)
classification criteria for TAK [23]. Computed tomog-
raphy (CT) scans encompassing the entire aorta and its
branches as a diagnostic evaluation were present for all
patients. Patients who only underwent localized imaging
work-up such as carotid duplex sonography or neck
angiography were excluded.
Electronic medical records of the study subjects were
reviewed, and information pertaining to age, sex, the
presence of hypertension (HTN), clinical symptoms and
signs, laboratory data at initial presentation including
erythrocyte sedimentation rate (ESR) and C-reactive
protein (CRP), and imaging data were collected. Regard-
ing clinical symptoms and signs, those attributable to
vascular involvement such as claudication, decreased
pulse, and blood pressure difference > 10 mmHg be-
tween arms, bruit, and carotidynia were reviewed. The
CT scans were utilized to assess the distribution of vas-
cular lesions and categorize them according to Hata’s
classification [13].
This study was approved by the Institutional Re-
view Board of Asan Medical Center in Seoul, South
Korea (IRB No. 2017-0857). The requirement for in-
formed consent was waived due to the retrospective
nature of the study.
Extravascular manifestations
The presence of peripheral arthritis, axial arthritis
(sacroiliitis), recurrent oral ulcers, erythema nodosum,
IBD (Crohn’s disease (CD) and ulcerative colitis (UC)),
and uveitis were determined from the electronic medical
records. A radiologist confirmed the presence of sacroi-
liitis from the CT scans that were taken for the diagnos-
tic work-up of TAK.
For patients with peripheral arthritis, the number and
distribution of joint involvements and positivity of
rheumatoid factor (RF), anti-cyclic citrullinated peptide
(anti-CCP) antibody, and antinuclear antibody (ANA) (if
the laboratory test was performed) were reviewed. The
number of joint involvements was classified as monoar-
thritis (1 joint involved), oligoarthritis (2–3 joints in-
volved), and polyarthritis (≥4 joints involved). The
distribution of joint involvement was assessed by the size
(small joints, large joints, or both), symmetry, and loca-
tion (upper extremities, lower extremities, or both) of
the joints involved. For patients with sacroiliitis, positiv-
ity of HLA-B27 (if the laboratory test was performed)
and whether they fulfilled the radiologic 1984 modified
New York criteria [24] were reviewed.
Statistical analysis
We described both vascular and extravascular manifesta-
tions. Continuous variables were expressed as the mean
± standard deviation (SD) and median (interquartile
range (IQR)) for a normal and a non-normal distribu-
tion, respectively. Categorical variables were expressed
as number (%). To evaluate the association between vas-
cular and extravascular manifestations, we performed lo-
gistic regression analysis. Univariate analysis was
performed for each variable, and variables determined
statistically significant (p < 0.05) were included in a
multivariate analysis.
Results
Baseline characteristics
During the study period, 268 TAK patients (185 and 83
from each cohort, respectively) with the ICD-10 code
M314 who met the 1990 ACR classification criteria for
TAK [23] were identified.
The mean age of the study population was 41.2 ±
14.2 years. The patients were predominantly female
(88.1%). A blood pressure difference of more than
10 mmHg between both arms, decreased pulse, bruit,
HTN, claudication, and carotidynia were observed in
84.1%, 56.7%, 45.8%, 44.8%, 33.9%, and 14.4% patients,
respectively. The median ESR result was 24.0 mm/h
(IQR 13.0–46.0), and the median CRP serum concen-
tration was 0.17 mg/dl (IQR 0.10–0.70) (Table 1).
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Patterns of vessel involvement
The most frequently involved vessel was the common
carotid artery (65.7%), followed by the subclavian artery
(63.4%) and the descending aorta (56.3%). The least in-
volved vessels were the iliac and pulmonary arteries
(both 11.2%). The most common pattern of vessel in-
volvement according to Hata’s classification [13] was
type V (44.8%) (Table 1).
Extravascular manifestations
Of the 268 patients, 19.0% displayed at least one extravas-
cular manifestation, the most common being arthritis,
followed by recurrent oral ulcers, IBD, and erythema
nodosum (11.9%, 8.6%, 2.6%, and 1.5%. respectively). Uve-
itis (unilateral anterior uveitis) was infrequently detected
(0.7%). The 32 arthritic patients comprised 19 with sacroi-
liitis and 16 with peripheral arthritis (Table 2).
As shown in Table 3, of the 19 patients with sacroiliitis,
the majority were female (89.5%) and HLA-B27 negative
(85.7%). The 1984 modified New York criteria [24] were
met by 68.4% of these patients, and 15.8% exhibited periph-
eral arthritis. Enthesitis, IBD, and uveitis were present in
one patient each. While type V vessel involvement was the
most common in the total study population, type IIB was
most frequently observed in the patients with sacroiliitis
Table 1 Baseline characteristics of the 268 Takayasu arteritis patients
Characteristic N = 268
Age (years), mean (± SD) 41.2 (± 14.2)
Female 236 (88.1%)
Hypertension 120 (44.8%)
Claudication (Na = 218) 74 (33.9%)
Decreased pulse (Na = 203) 115 (56.7%)
Blood pressure difference > 10 mmHg (Na = 239) 201 (84.1%)
Bruit (Na = 203) 93 (45.8%)
Carotidynia (Na = 201) 29 (14.4%)
ESR (mm/h), median (IQR) 24.0 (13.0–46.0)
CRP (mg/dl), median (IQR) 0.17 (0.10–0.70)
Vessel involvement
Common carotid artery 176 (65.7%)
Subclavian artery 170 (63.4%)
Ascending aorta 84 (31.3%)
Aortic arch 100 (37.3%)
Descending aorta 151 (56.3%)
Abdominal aorta 124 (46.3%)
Renal artery 54 (20.1%)
Iliac artery 30 (11.2%)
Pulmonary artery 30 (11.2%)
Hata’s classification
Type I 54 (20.1%)
Type IIA 23 (8.6%)
Type IIB 55 (20.5%)
Type III 10 (3.7%)
Type IV 6 (2.2%)
Type V 120 (44.8%)
Data presented as n (%) unless stated otherwise
SD standard deviation, ESR erythrocyte sedimentation rate, IQR interquartile
range, CRP C-reactive protein
aPatients with missing data excluded
Table 2 Extravascular manifestations of Takayasu arteritis
Manifestation N = 268
At least one extravascular manifestation present 51 (19.0%)
Arthritis 32 (11.9%)
Axial arthritis (sacroiliitis) 19 (7.1%)
Peripheral arthritis 16 (6.0%)
Recurrent oral ulcers 23 (8.6%)
Inflammatory bowel disease 7 (2.6%)
Crohn’s disease 4 (1.5%)
Ulcerative colitis 3 (1.1%)
Erythema nodosum 4 (1.5%)
Uveitisa 2 (0.7%)
Data presented as n (%)
aBoth patients had unilateral anterior uveitis
Table 3 Characteristics of the 19 Takayasu arteritis patients with
axial arthritis (sacroiliitis)
Characteristic N = 19
Age (years), mean (± SD) 38.9 (±
14.9)
Sex
Male 2 (10.5%)
Female 17 (89.5%)
HLA-B27 (Na = 7) 1 (14.3%)
Sacroiliitis meeting 1984 modified New York criteriab for
AS
13 (68.4%)
Peripheral arthritis 3 (15.8%)
Enthesitis 1 (5.3%)
Inflammatory bowel disease 1 (5.3%)
Uveitis 1 (5.3%)
Hata’s classification
Type I 3 (15.8%)
Type IIA 2 (10.5%)
Type IIB 7 (36.8%)
Type III 1 (5.3%)
Type IV 0 (0.0%)
Type V 6 (31.6%)
Data presented as n (%) unless stated otherwise
SD standard deviation, AS ankylosing spondylitis
aPatients with missing data excluded
bRadiologic criteria of the 1984 modified New York criteria [24]: sacroiliitis
grade ≥ 2 bilaterally or grade 3–4 unilaterally
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(36.8%). Representative images of a TAK patient with
sacroiliitis are presented in Fig. 1.
The characteristics of the 16 patients with peripheral
arthritis are presented in Table 4. Monoarthritis, oligoar-
thritis, and polyarthritis were observed in 37.5%, 43.8%, and
18.8% of patients, respectively. Regarding joint distribution,
large joint involvement was most common (62.5%), and the
shoulder joint most frequently affected. The majority of pa-
tients exhibited asymmetric joint involvement (87.5%). The
locations of involved joints were approximately evenly dis-
tributed between the upper extremities, the lower extrem-
ities, and both the upper and lower extremities together. RF
was positive in 9.1%, and none of the patients were positive
for anti-CCP antibody or ANA. The most common vessel
involvement was type IIB (50%), which is concordant with
that of the study subjects with sacroiliitis.
Vascular manifestations associated with arthritis
Logistic regression analysis was performed to evaluate
vascular manifestations associated with arthritis in TAK
patients (Table 5). On univariate analysis, ESR, CRP, and
type IIB vessel involvement were significantly associated
with arthritis (p = 0.007, p = 0.027, and p = 0.004, re-
spectively). Type V vessel involvement was inversely as-
sociated with arthritis (p = 0.048). On multivariate
analysis, ESR (p = 0.012) and type IIB (p = 0.007)
remained significant.
Discussion
In this study, we determined that extravascular manifes-
tations of TAK were not rare, with a prevalence of
19.0%. In particular, arthritis (11.9%) was the most com-
mon extravascular manifestation. To the best of our
knowledge, this is the first study describing the extravas-
cular manifestations of TAK in detail.
Sacroiliitis was present in 7.1% TAK patients. Consider-
ing that the global prevalence of SpA is approximately 1%
[25], the proportion of TAK patients with sacroiliitis ap-
pears high. Although not clear to date, there might be a
shared genetic background between TAK and sacroiliitis,
Fig. 1 Computed tomography (CT) images of Takayasu arteritis (TAK) patient who exhibited sacroiliitis as an extravascular manifestation. Female
patient, 29 years old, negative for HLA-B27. a Complete occlusion in left subclavian artery (arrowhead). b Concentric wall thickening in left
common carotid artery (arrowhead). c Sclerosis in both sacroiliac joints and erosion with joint space widening suggesting grade III sacroiliitis.
d Vertebral corner inflammations, especially in lumbar spines (L2 and L5)
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which could play a central role in their co-occurrence.
Further study regarding this issue could aid in elucidating
the pathophysiologic background of these diseases. We
discovered that the characteristics of sacroiliitis in TAK
differed from SpA patients in general, being predomin-
antly female (89.5%) and exhibiting a low incidence of
HLA-B27 positivity (14.3%) [25–27]. This finding is con-
sistent with a previous study [15] that also demonstrated
female predominance and low HLA-B27 positivity. Fur-
thermore, the presence of SpA features other than sacroi-
liitis in these patients was relatively low (peripheral
arthritis 15.8%, enthesitis 5.3%, uveitis 5.3%, IBD 5.3%)
compared to SpA patients in general (peripheral arthritis
39.8–58.0%, enthesitis 37.8–50.0%, uveitis 8.5–27.0%, IBD
1.8–11.0%) [28]. Considering that aortitis is one of the car-
diovascular manifestations observed in ankylosing spon-
dylitis and other forms of SpA [29], it can be challenging
to differentiate TAK patients with sacroiliitis from SpA pa-
tients with aortitis. The aforementioned differences in the
characteristics of sacroiliitis between these two patient
types could provide clues in distinguishing one from
another.
Peripheral arthritis was observed in 6.0% of TAK pa-
tients. This manifestation was characterized by an asym-
metric oligoarthritis pattern, mostly involving the large
joints. This was similar to the pattern observed in SpA
Table 4 Characteristics of the 16 Takayasu arteritis patients with
peripheral arthritis
Characteristic N = 16
Age (years), mean (± SD) 41.6 (± 14.7)
Sex
Male 2 (12.5%)
Female 14 (87.5%)
Number of joints involved
Monoarthritis (1 joint) 6 (37.5%)
Oligoarthritis (2–3 joints) 7 (43.8%)
Polyarthritis (≥ 4 joints) 3 (18.8%)
Distribution of joint involvement
Size
Small joints 3 (18.8%)
Large jointsa 10 (62.5%)
Small and large joints 3 (18.8%)
Symmetry
Symmetric 2 (12.5%)
Asymmetric 14 (87.5%)
Location
Upper extremities 6 (37.5%)
Lower extremities 5 (31.3%)
Upper and lower extremities 5 (31.3%)
RF (Nb = 11) 1 (9.1%)
Anti-CCP antibody (Nb = 11) 0 (0.0%)
ANA (Nb = 11) 0 (0.0%)
Hata’s classification
Type I 2 (12.5%)
Type IIA 1 (6.3%)
Type IIB 8 (50.0%)
Type III 1 (6.3%)
Type IV 1 (6.3%)
Type V 3 (18.8%)
Data presented as n (%) unless stated otherwise
SD standard deviation, RF rheumatoid factor, CCP cyclic citrullinated peptide,
ANA antinuclear antibody
aMost commonly involved was the shoulder joint
bPatients with missing data excluded
Table 5 Vascular manifestations associated with arthritis in
Takayasu arteritis
Characteristic Unadjusted OR 95% CI P value
Univariate analysis
ESR 1.015 1.004–1.025 0.007*
CRP 1.123 1.013–1.245 0.027*
Claudication 0.687 0.275–1.718 0.422
Decreased pulse 0.816 0.342–1.946 0.646
BP difference > 10 mmHg 1.657 0.474–5.792 0.429
Bruit 1.096 0.459–2.613 0.837
Carotidynia 0.877 0.243–3.163 0.841
Common carotid artery 1.658 0.713–3.853 0.240
Subclavian artery 2.241 0.931–5.394 0.072
Ascending aorta 1.844 0.869–3.913 0.111
Aortic arch 1.567 0.745–3.297 0.236
Descending aorta 2.156 0.957–4.857 0.064
Abdominal aorta 0.486 0.221–1.072 0.074
Renal artery 1.126 0.459–2.761 0.795
Iliac artery 0.230 0.030–1.751 0.156
Pulmonary artery 0.495 0.112–2.186 0.354
Type I 0.707 0.259–1.930 0.498
Type IIA 1.117 0.313–3.994 0.865
Type IIB 3.160 1.448–6.897 0.004*
Type III 0.814 0.100–6.643 0.847
Type IV 1.490 0.169–-13.177 0.720
Type V 0.441 0.196–0.992 0.048*
Multivariate analysis
ESR 1.014 1.003–1.025 0.012*
CRP 1.052 0.911–1.215 0.489
Type IIB 2.956 1.337–6.537 0.007*
Type V 0.634 0.243–1.652 0.351
OR odds ratio, CI confidence interval, ESR erythrocyte sedimentation rate, CRP
C-reactive protein, BP blood pressure
*Value considered significant (p < 0.05)
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(asymmetric oligoarthritis with lower extremity predom-
inance) [30] except that an even distribution between
the upper and lower extremities was observed.
Interestingly, the most common type of vessel involve-
ment in TAK patients with arthritis (axial and/or periph-
eral arthritis) was type IIB, differing from the total study
population where type V was most frequently observed.
Furthermore, in the multivariate logistic regression ana-
lysis evaluating the association between arthritis and vas-
cular manifestations, type IIB was associated with
arthritis approximately three times higher than nontype
IIB. Therefore, TAK patients with type IIB should be
carefully monitored for arthritis.
In our study, the prevalence of IBD (2.6%) in TAK pa-
tients appeared low compared to previous reports (5.8–
8.3%) [16, 31]. However, considering that the prevalence
of CD and UC are 0.01% and 0.03%, respectively, in the
general Korean population [32], a prevalence of 2.6%
IBD in our TAK patients is obviously higher than that of
the general population. This is consistent with a previ-
ous study reporting a higher prevalence of IBD in TAK
patients than that in the general population [16, 31].
Recurrent oral ulcers (8.6%) were the second most
common extravascular manifestation in our study,
whereas erythema nodosum (1.5%) and uveitis (0.7%)
were rarely observed. Recurrent oral ulcers, erythema
nodosum, and monoarthritis or oligoarthritis are mani-
festations that are also observed in Behcet’s disease, as
well as inflammation of large vessels [33]. Thus, it may
be confusing to distinguish TAK from Behcet’s disease.
However, a notable difference between TAK and Behcet’s
disease is the absence of genital ulcers. In our data, none
of the TAK patients exhibited genital ulcers, which have
the highest discriminatory value in the International
Study Group for Behcet’s Disease criteria [34]. Further-
more, occlusion or stenosis due to homogeneous con-
centric wall thickness favors TAK, whereas thrombotic
occlusion or a solitary aneurysm is more likely in Beh-
cet’s disease [33].
The present study has some limitations. First, this
study was retrospective. Although not many, there were
some missing data concerning clinical symptoms and
signs. Therefore, there might be other extravascular
manifestations that we have not identified. Second, only
Korean TAK patients were included, and other ethnic
populations could display different results. Thus, further
studies with subjects from different ethnic populations
are required. Despite these limitations, considering that
TAK is such a rare disease, our results are strengthened
by the relatively large number of patients.
Conclusions
In summary, we have shown that extravascular manifes-
tations of TAK are observed in up to one-fifth of TAK
patients. The most common extravascular manifestation
was arthritis (axial arthritis and peripheral arthritis), and
Hata’s type IIB pattern of vessel involvement and a high
ESR were associated with the presence of arthritis. The
presented results are meaningful in that they provide cli-
nicians with a better understanding of the accompanying
extravascular manifestations of this rare disease.
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